Table 2 Mutations found in 92 NSCLC FFPE samples
From: Molecular profiling of lung cancer specimens and liquid biopsies using MALDI-TOF mass spectrometry
Classification | Total cases | Mutated cases | EGFR | KRAS | BRAF | ALK | PIK3CA | ERBB2 | DDR2 | AKT | MEK1 |
|---|---|---|---|---|---|---|---|---|---|---|---|
ADC | 78 | 45 (57.7%) | 12 (15.4%) | 29 (37.2%) | 1 (1.3%) | – | – | 3 (3.8%) | – | 2 (2.6%) | – |
SCC | 11 | 3 (27.3%) | – | – | – | – | 3 (27.3%) | – | – | – | – |
NSCLC | 3 | 1 (33.3%) | – | 1 (33.3%) | – | – | – | – | – | – | – |